- Home
- NVEC vs EBS Comparison
NVEC vs EBS Comparison
Compare NVEC & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVEC
- EBS
- Stock Information
- Founded
- NVEC 1989
- EBS 1998
- Country
- NVEC United States
- EBS United States
- Employees
- NVEC N/A
- EBS 900
- Industry
- NVEC Semiconductors
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- NVEC Technology
- EBS Health Care
- Exchange
- NVEC Nasdaq
- EBS Nasdaq
- Market Cap
- NVEC 359.6M
- EBS 337.6M
- IPO Year
- NVEC 1996
- EBS 2006
- Fundamental
- Price
- NVEC $72.90
- EBS $6.72
- Analyst Decision
- NVEC
- EBS Strong Buy
- Analyst Count
- NVEC 0
- EBS 3
- Target Price
- NVEC N/A
- EBS $14.33
- AVG Volume (30 Days)
- NVEC 89.0K
- EBS 944.5K
- Earning Date
- NVEC 07-16-2025
- EBS 08-05-2025
- Dividend Yield
- NVEC 5.59%
- EBS N/A
- EPS Growth
- NVEC N/A
- EBS N/A
- EPS
- NVEC 3.11
- EBS N/A
- Revenue
- NVEC $25,874,694.00
- EBS $965,400,000.00
- Revenue This Year
- NVEC N/A
- EBS N/A
- Revenue Next Year
- NVEC N/A
- EBS $18.88
- P/E Ratio
- NVEC $23.01
- EBS N/A
- Revenue Growth
- NVEC N/A
- EBS N/A
- 52 Week Low
- NVEC $51.50
- EBS $4.02
- 52 Week High
- NVEC $89.98
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- NVEC 57.54
- EBS 58.49
- Support Level
- NVEC $67.81
- EBS $6.04
- Resistance Level
- NVEC $72.32
- EBS $6.98
- Average True Range (ATR)
- NVEC 2.15
- EBS 0.35
- MACD
- NVEC -0.31
- EBS -0.01
- Stochastic Oscillator
- NVEC 66.19
- EBS 73.20
About NVEC NVE Corporation
NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.